PlexBio Co., Ltd. Stock Price

TPEX:6572 Community·NT$978.5m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6572 Share Price Performance

NT$0

-12.00 (-100.00%)

NT$0

-12.00 (-100.00%)

NT$0

Thu, 20 Nov 25

Share Pricen/a

6572 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks

1 Reward

View Full Analysis

PlexBio Co., Ltd. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.62
: 32.13%
: -42.15%
: 0%

View Full Analysis

About 6572

Founded: 2009
Employees: n/a
CEO: Ting Cao
WebsiteView website: www.plexbio.com

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation extraction kits; IntelliPlex platform that is designed for pCode technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-CoV-2 detection test kits/flu kits and IntelliPlex SARS-CoV-2 variant analysis kits; and pCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.